Skip to content
★ Sign in to follow
IH

Isec Healthcare Ltd. Stock: price and insider trades · Singapore

ISIN SG1AD9000001SG·Mcap SGD 167MHealth Care

No insider purchase over the last 90 days. The latest, by Dr Wong Jun Shyan, was filed 18 Sept 2024.

Isec Healthcare Ltd.: what insiders have been doing

Every trade that managers of Isec Healthcare Ltd. disclose to SGX is tracked on this page. The company sits in the Health Care sector. Isec Healthcare Ltd. has had no insider filing for more than a year; the last one goes back to 18 September 2024.

Over the whole record (from 2017), the tally stands at 17 purchases and 9 sales.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and EssilorLuxottica. Source: insider filings from SGX. Past trades are no guide to future returns.

Insider Decl.
37
Thresholds
n/a
Buy Volume
€82M
17 ops. · all time
Sell Volume
€53M
9 ops. · all time

Since the insiders bought

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 6,019 of 26,911 companies
65.6
score / 100
Value
61
Quality
71
FCF yld-0.4%
Earn yld8.0%
EV/EBITDA8.3x
ROE13%
Gross mgn42%
Net mgn17%
Debt/EBITDA1.2x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

SGD 0.29
Analyst consensus
·
Income statement
RevenueSGD 79.2M
Gross profitSGD 33.4M42% margin
EBITDASGD 23.3M29% margin
Net incomeSGD 13.4M15.5% margin
Valuation
PER (trailing)14.5x
P/Book1.6x
Beta-0.20
Balance sheet & cash
Market capSGD 167M
Total debtSGD 27.1M
Free Cash Flow-SGD 640k
Debt / Equity25%
Profitability & ownership
ROE12.6%
ROA7.9%
% insiders70.0%
% institutions0.0%
Last declaration on 18 September 2024
Declarations37 total
  • ▲
    Director/CEOExecutives
    9,250 SGD34SGX
    25,000 shares@ SGD 0.370.2% of flowShareSGX-STISIN SG1AD9000001SGX:WSDDGX6ZSH1A9WSP
    Canonical exit: 16 Dec 2024 (T+90)
  • ▼
    Director/CEOExecutives
    5M SGD26SGX
    14,283,769 shares@ SGD 0.35538.4% of flowShareSGX-STISIN SG1AD9000001SGX:5QO9M57H7KD8N1XA
  • ▲
    Related company / holdingExecutives
    5M SGD9SGX
    14,283,769 shares@ SGD 0.35538.4% of flowShareSGX-STISIN SG1AD9000001SGX:NQGVMK3G33FLUBZT
    Canonical exit: 17 Nov 2024 (T+90)
  • ▼
    Director/CEOExecutives
    8M SGD28SGX
    22,972,677 shares@ SGD 0.357161.6% of flowShareSGX-STISIN SG1AD9000001SGX:RH3DQEY1HPUOND4O
  • ▲
    Related company / holdingExecutives
    8M SGD11SGX
    22,972,677 shares@ SGD 0.357161.6% of flowShareSGX-STISIN SG1AD9000001SGX:HWMX3Y40E6G6UYFN
    Canonical exit: 14 Mar 2024 (T+90)
  • ▼
    Substantial ShareholderExecutives(filed)
    8M SGD13SGX
    22,972,677 shares@ SGD 0.3571100.0% of flowShareSGX-STISIN SG1AD9000001SGX:D93KN95DDK4MNNGT
  • ▲
    Director/CEOExecutives
    8,200 SGD25SGX
    20,000 shares@ SGD 0.4126.6% of flowShareSGX-STISIN SG1AD9000001SGX:LMS90RXPWWXT0Z00
    Canonical exit: 7 Jan 2024 (T+90)
  • ▲
    Director/CEOExecutives
    49,158 SGD37SGX
    169,510 shares@ SGD 0.290.9% of flowShareSGX-STISIN SG1AD9000001SGX:0C0Q82PBIBEBYJZS
    Canonical exit: 20 Sept 2023 (T+90)
  • ▲
    Director/CEOExecutives
    45,843 SGD34SGX
    158,080 shares@ SGD 0.290.1% of flowShareSGX-STISIN SG1AD9000001SGX:2588Y2NZ19W86UQG
    Canonical exit: 20 Sept 2023 (T+90)
  • ▲
    Director/CEOExecutives
    14,500 SGD30SGX
    50,000 shares@ SGD 0.29100.0% of flowShareSGX-STISIN SG1AD9000001SGX:2LKQZQCB2JFJ51YC
    Canonical exit: 20 Sept 2023 (T+90)
  • ●
    Director/CEOExecutives
    0SGX
    12,462,934 sharesShareSGX-STISIN SG1AD9000001SGX:47PFM6S2XQQBR7ST
  • ▲
    Director/CEOExecutives
    21,846 SGD29SGX
    66,200 shares@ SGD 0.3373.4% of flowShareSGX-STISIN SG1AD9000001SGX:N2MEFLIVYWZEUGZM
    Canonical exit: 22 Dec 2022 (T+90)
  • ▲
    Director/CEOExecutives
    5,730 SGD22SGX
    19,100 shares@ SGD 0.300.1% of flowShareSGX-STISIN SG1AD9000001SGX:DBO7I7RFKCTDSP0T
    Canonical exit: 26 Sept 2022 (T+90)
  • ●
    Related company / holdingExecutives
    0SGX
    ShareSGX-STISIN SG1AD9000001SGX:BF46888FJBJQXHV5
  • ▲
    Related company / holdingExecutives
    2M SGD5SGX
    5,000,000 shares@ SGD 0.311.8% of flowShareSGX-STISIN SG1AD9000001SGX:LV6YKB9IRUL1JVNP
    Canonical exit: 8 Sept 2021 (T+90)
  • ▼
    Director/CEOExecutives
    2M SGD25SGX
    5,000,000 shares@ SGD 0.3127.0% of flowShareSGX-STISIN SG1AD9000001SGX:W1R43RW8SLKQJCZL
  • ●
    Substantial ShareholderExecutives(filed)
    0SGX
    ShareSGX-STISIN SG1AD9000001SGX:K2IBFEB6RFGEV75W
  • ●
    Substantial ShareholderExecutives(filed)
    0SGX
    ShareSGX-STISIN SG1AD9000001SGX:CL0SA01UDDK7JDCV
  • ●
    Substantial ShareholderExecutives(filed)
    0SGX
    ShareSGX-STISIN SG1AD9000001SGX:VR3SEZXZZCWJDA1B
  • ●
    Related company / holdingExecutives
    0SGX
    ShareSGX-STISIN SG1AD9000001SGX:QH9HIE2I80GRQ9KO
  • ●
    Director/CEOExecutives(filed)
    0SGX
    ShareSGX-STISIN SG1AD9000001SGX:EJPFK9EIMR8Q9F44
  • ▲
    Related company / holdingExecutives
    41M SGD7SGX
    114,595,353 shares@ SGD 0.3621.7% of flowShareSGX-STISIN SG1AD9000001SGX:2BE2K5OUJX4DLPE9
    Canonical exit: 19 Mar 2020 (T+90)
  • ▼
    Director/CEOExecutives
    144,000 SGD42SGX
    400,000 shares@ SGD 0.36100.0% of flowShareSGX-STISIN SG1AD9000001SGX:HSMET6UTV71NQ519
  • ▼
    Director/CEOExecutives
    144,000 SGD30SGX
    400,000 shares@ SGD 0.36100.0% of flowShareSGX-STISIN SG1AD9000001SGX:LHJES7Z4PLGGRXKA
  • ▲
    Related company / holdingExecutives
    67M SGD13SGX
    186,321,991 shares@ SGD 0.3681.5% of flowShareSGX-STISIN SG1AD9000001SGX:TS07Z2OGA4U5JBYK
    Canonical exit: 23 Jan 2020 (T+90)

25 of 37 declarations

About Isec Healthcare Ltd.

Isec Healthcare Ltd. is a company listed on the XSES market, specializing in the healthcare sector. It focuses on providing innovative services and solutions to enhance the quality of patient care.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations